# Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)

Study · id `cardio:ct-nct01371058` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01371058](<https://clinicaltrials.gov/study/NCT01371058>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01371058

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 350 participants.

## Technical summary

Registry record NCT01371058. Randomized; no masking; primary purpose prevention. Start 2011-03 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 350 participants (enrolled count; ClinicalTrials.gov record NCT01371058, source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01371058, source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01371058, source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)
- Completion: 2013-09 (actual) (ClinicalTrials.gov record NCT01371058, source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01371058, source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01371058-2015-12-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
- Acronym: spirit
- Condition: Coronary Artery Disease
- Intervention (Drug): high maintenance clopidogrel
- Intervention (Drug): routine dual antiplatelet
- Intervention (Drug): policosanol plus dual antiplatelet
- Lead sponsor: Shenyang Northern Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shenyang Northern Hospital (`cardio:org-shenyang-northern-hospital`)

## Provenance

Content hash: 01d2ae8dff826abfcbd5983a1842fbd9a1a0e66e875aa0fb368f62d376bbb681
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
